MyAverix Finance
SA · Healthcare
United Therapeutics Corporation (U2TH34)
Drug Manufacturers - Specialty & Generic
United Therapeutics Corporation (U2TH34) is listed on SA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $126.14B, P/E ratio is 19.71, net margin is 41.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for U2TH34
United Therapeutics Corporation (U2TH34) — FAQ
What is United Therapeutics Corporation's market cap?
United Therapeutics Corporation (U2TH34) has a reported market cap of $126.14B (data as of 2026-03-29).
What is U2TH34's P/E ratio?
The price-to-earnings (P/E) ratio for United Therapeutics Corporation (U2TH34) is 19.71 (data as of 2026-03-29).
Does United Therapeutics Corporation pay a dividend?
Dividend yield is not available in the current snapshot for United Therapeutics Corporation (U2TH34). Check the MyAverix Finance app for the latest dividend data.
What sector is United Therapeutics Corporation in?
United Therapeutics Corporation (U2TH34) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is U2TH34 listed on?
U2TH34 is listed on SA.
What is United Therapeutics Corporation's net margin?
United Therapeutics Corporation (U2TH34) reports a net margin of 41.9% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.